Daily co-injection of PIP2 liposomes into LLC-allografted mice treated with the Cds2 vMO does reverse tumor growth and vascular density defects noted with Cds2 vMO treatment alone (Fig. 2e–g; Supplementary Fig. 11F, G). Here, CDS2 is linked to neoplasm.